Advertisement

Flipkart Acquires Majority Stake in Minivet AI Labs to Boost Generative AI-Led Ecommerce Content

Walmart-owned Flipkart has acquired a majority stake in Minivet AI Labs, a generative AI startup specialising in video and visual content creation for ecommerce platforms. While the financial terms of the deal were not disclosed, the acquisition underscores Flipkart’s accelerating focus on embedding artificial intelligence across its product discovery, cataloguing, and seller enablement workflows.

By Super Admin | December 22, 2025

Visionary Leader Nishchai Nevrekar Appointed as Chief Digital Officer at Sterlite Technologies Limited

STL - Sterlite Technologies Limited (STL), part of the Vedanta Group, has appointed Nishchai Nevrekar as Chief Digital Officer, marking a significant step in advancing itsSTL - Sterlite Technologies Limited (STL), part of the Vedanta Group, has appointed Nishchai Nevrekar as Chief Digital Officer, marking a significant step in advancing its digital-first vision. Nishchai brings over 15 years of leadership experience across digital transformation, customer experience, supply chain, and advanced analytics, with a strong track record of delivering large-scale global technology programs. Prior to joining STL, Nishchai spent nearly eight transformative years at Pidilite Industries, where he led enterprise-wide digital strategy, built high-impact digital teams, and delivered platforms spanning sales, manufacturing, analytics, and automation. His career also includes leadership roles across FMCG, luxury retail, chemicals, and consumer durables, with successful project implementations in eight-plus countries.

By Super Admin | December 22, 2025

Pooja Vatsyayan Appointed as Vice President, Program and Commercialization Lead at Alkeus Pharmaceuticals

Visionary Leader Pooja Vatsyayan has begun a new professional chapter as Vice President, Program and Commercialization Lead at Alkeus Pharmaceuticals, Inc., marking a significant leadership addition as the company advances innovative therapies for retinal diseases. In this strategic role, she will lead the integrated global program strategy and oversee cross-functional efforts to develop and commercialize gildeuretinol for Stargardt disease, ensuring strong alignment between clinical progress and market readiness.

By Super Admin | December 22, 2025